News & Updates

Show Multimedia Only

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

29 Jun 2026 by

Among patients with inflammatory arthritis receiving biologic or targeted synthetic disease-modifying anti-rheumatic drugs, those with overweight or obesity face an increased risk of COVID-19 infection, according to a study from Singapore.

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

29 Jun 2026

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

28 Jun 2026

Treatment with oral glucocorticoids may contribute to elevated risks of adverse psychiatric outcomes, including the onset and relapse of common psychiatric disorders, as shown in a population-based cohort study.

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

28 Jun 2026

Psoriatic arthritis disease activity worsens during perimenopause

28 Jun 2026 by

Women with psoriatic arthritis (PsA) appear to experience increased disease activity, measured either objectively or subjectively, during the perimenopause stage, as shown in a study.

Psoriatic arthritis disease activity worsens during perimenopause

28 Jun 2026

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

26 Jun 2026 by

The oral Janus kinase (JAK) inhibitor baricitinib has demonstrated efficacy in inducing and maintaining glucocorticoid-free remission in patients with early polymyalgia rheumatica, according to the phase 3 JAK-Spare trial.

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

26 Jun 2026

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

24 Jun 2026 by

Treatment with secukinumab helps reduce symptoms and disease activity in Chinese children with enthesitis-related arthritis, as shown in a retrospective study.

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

24 Jun 2026

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

20 Jun 2026

The use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) among adults with obesity and concomitant autoimmune diseases appears to lower the incidence of thromboembolic events, emergency department visits, and mortality, according to a study.

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

20 Jun 2026

Sublingual cyclobenzaprine fares well in fibromyalgia

17 Jun 2026 by

Findings from the phase III RESILIENT study show that a sublingual formulation of cyclobenzaprine (CBP SL) may benefit individuals with fibromyalgia.

Sublingual cyclobenzaprine fares well in fibromyalgia

17 Jun 2026

RMDs impact sexual health

15 Jun 2026 by

Rheumatic and musculoskeletal diseases (RMD) may negatively impact sexual well-being, a study suggests.

RMDs impact sexual health

15 Jun 2026

Original New Drug Application Approvals by US FDA (1-15 May 2026)

12 Jun 2026

New drug applications approved by US FDA as of 1-15 May 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 May 2026)

12 Jun 2026

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

A significant proportion of rheumatology patients have been diagnosed with anxiety, depression, or fibromyalgia (FM), reveals a study, noting the importance of including screening for clinical decisions at all routine encounters.

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

Inflammatory arthritis patients with overweight, obesity at high risk of COVID-19

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

Glucocorticoid treatment carries risk of adverse psychiatric outcomes

Psoriatic arthritis disease activity worsens during perimenopause

Psoriatic arthritis disease activity worsens during perimenopause

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

Baricitinib a promising steroid-sparing option in early polymyalgia rheumatica

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

Secukinumab improves outcomes in Chinese children with enthesitis-related arthritis

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

GLP‐1RA offers cardiovascular, survival benefits in high-risk population

Sublingual cyclobenzaprine fares well in fibromyalgia

Sublingual cyclobenzaprine fares well in fibromyalgia

RMDs impact sexual health

RMDs impact sexual health

Original New Drug Application Approvals by US FDA (1-15 May 2026)

Original New Drug Application Approvals by US FDA (1-15 May 2026)

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Rheumatology patients must undergo screening for anxiety, depression, FM: study